Nicotinic α5 receptor subunit mRNA expression is associated with distant 5′ upstream polymorphisms

Berrettini W, Yuan X, Tozzi F et al: Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 2008; 13: 368–373.

Bierut LJ, Stitzel JA, Wang JC et al: Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 2008; 165: 1163–1171.

Saccone SF, Hinrichs AL, Saccone NL et al: Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2007; 16: 36–49.

Saccone NL, Saccone SF, Hinrichs AL et al: Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 453–466.

Saccone NL, Wang JC, Breslau N et al: The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res 2009; 69: 6848–6856.

Sherva R, Kranzler HR, Yu Y et al: Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology 2010, e-pub ahead of print 19 May 2010. doi: 10.1038/npp.2010.64.

Sherva R, Wilhelmsen K, Pomerleau CS et al: Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with ‘pleasurable buzz’ during early experimentation with smoking. Addiction 2008; 103: 1544–1552.

Stevens VL, Bierut LJ, Talbot JT et al: Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol Biomarkers Prev 2008; 17: 3517–3525.

The Tobacco and Genetics Consortium: Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nature Genet 2010; 42: 441–447.

Wang JC, Cruchaga C, Saccone NL et al: Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet 2009; 18: 3125–3135.

Weiss RB, Baker TB, Cannon DS et al: A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 2008; 4: e1000125.

Amos CI, Wu X, Broderick P et al: Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40: 616–622.

Hung RJ, McKay JD, Gaborieau V et al: A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452: 633–637.

Liu P, Yang P, Wu X et al: A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. Cancer Res 2010; 70: 3128–3135.

Pillai SG, Ge D, Zhu G et al: A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009; 5: e1000421.

Grucza RA, Wang JC, Stitzel JA et al: A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence. Biol Psychiatry 2008; 64: 922–929.

Schlaepfer IR, Hoft NR, Collins AC et al: The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry 2008; 63: 1039–1046.

Wang JC, Grucza R, Cruchaga C et al: Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry 2009; 14: 501–510.

Johnson AD, Zhang Y, Papp AC et al: Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Pharmacogenet Genomics 2008; 18: 781–791.

Wang D, Sadee W : Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1). AAPS J 2006; 8: E515–E520.

Ge B, Pokholok DK, Kwan T et al: Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet 2009; 41: 1216–1222.

Miller SA, Dykes DD, Polesky HF : A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

Lim JE, Pinsonneault J, Sadee W, Saffen D : Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons. Mol Psychiatry 2007; 12: 491–501.

Kent WJ, Sugnet CW, Furey TS et al: The human genome browser at UCSC. Genome Res 2002; 12: 996–1006.

Johnson AD, Handsaker RE, Pulit S, Nizzari MM, O'Donnell CJ, de Bakker PIW : SNAP: A web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008; 24: 2938–2939.

Su AI, Cooke MP, Ching KA et al: Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 2002; 99: 4465–4470.

Wittkopp PJ, Haerum BK, Clark AG : Evolutionary changes in cis and trans gene regulation. Nature 2004; 430: 85–88.

Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B : JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 2004; 32: D91–D94.

Vlieghe D, Sandelin A, De Bleser PJ et al: A new generation of JASPAR, the open-access repository for transcription factor binding site profiles. Nucleic Acids Res 2006; 34: D95–D97.

Kumar P, Pandey KN : Cooperative activation of Npr1 gene transcription and expression by interaction of Ets-1 and p300. Hypertension 2009; 54: 172–178.

Yang C, Shapiro LH, Rivera M, Kumar A, Brindle PK : A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol Cell Biol 1998; 18: 2218–2229.

Bolon I, Gouyer V, Devouassoux M et al: Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 1995; 147: 1298–1310.

Yamaguchi E, Nakayama T, Nanashima A et al: Ets-1 proto-oncogene as a potential predictor for poor prognosis of lung adenocarcinoma. Tohoku J Exp Med 2007; 213: 41–50.

Falvella FS, Galvan A, Frullanti E et al: Transcription deregulation at the 15q25 locus in association with lung adenocarcinoma risk. Clin Cancer Res 2009; 15: 1837–1842.

Improgo MR, Schlichting NA, Cortes RY, Zhao-Shea R, Tapper AR, Gardner PD : ASCL1 regulates the expression of the CHRNA5/A3/B4 lung cancer susceptibility locus. Mol Cancer Res 2010; 8: 194–203.

Pennacchio LA, Loots GG, Nobrega MA, Ovcharenko I : Predicting tissue-specific enhancers in the human genome. Genome Res 2007; 17: 201–211.